HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
100.99
-3.14 (-3.02%)
Jul 30, 2026, 4:00 PM EDT - Market closed
HealthEquity Cash Flow Statement
Financials in millions USD. Fiscal year is February - January.
Millions USD. Fiscal year is Feb - Jan.
Operating Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Net Income | 230.7 | 215.2 | 96.7 | 55.71 | -26.14 | -44.29 |
Depreciation & Amortization | 154.13 | 154.66 | 162.45 | 153.08 | 161.2 | 137.19 |
Stock-Based Compensation | 78.13 | 73.06 | 96.43 | 77.15 | 62.61 | 52.75 |
Other Adjustments | 49.6 | 40.79 | -9.19 | -9.99 | -13.65 | -6.28 |
Change in Receivables | -5.75 | -5.69 | -13.11 | -8.06 | -9.57 | -11.2 |
Changes in Accounts Payable | -2.59 | 1.71 | 8.89 | -0.2 | -26.67 | -2.18 |
Changes in Accrued Expenses | 2.16 | -8.81 | 17.76 | 2.95 | -1.28 | -3.66 |
Changes in Other Operating Activities | -16.3 | -13.83 | -20.06 | -27.82 | 4.16 | 18.66 |
Operating Cash Flow | 489.88 | 457.09 | 339.86 | 242.83 | 150.65 | 141 |
Operating Cash Flow Growth | 44.44% | 34.50% | 39.96% | 61.19% | 6.85% | -22.37% |
Investing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Capital Expenditures | -2.25 | -1.97 | -2.08 | -1.69 | -3.37 | -8.91 |
Purchases of Intangible Assets | -46.39 | -46.52 | -51.13 | -41.12 | -45.17 | -62.71 |
Proceeds from Sale of Investments | - | - | - | - | - | 2.37 |
Cash Acquisitions | - | - | - | - | - | -504.53 |
Other Investing Activities | - | 1.34 | -452.24 | -3.26 | -70.58 | -65.47 |
Investing Cash Flow | -44.9 | -47.14 | -505.45 | -46.07 | -119.13 | -639.25 |
Financing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Long-Term Debt Issued | - | - | 736.88 | - | - | 950 |
Long-Term Debt Repaid | -115 | -100 | -561.88 | -54.38 | -8.75 | -1,003 |
Net Long-Term Debt Issued (Repaid) | -115 | -100 | 175 | -54.38 | -8.75 | -53.13 |
Issuance of Common Stock | 10.87 | 11.41 | 9.43 | 6.47 | 6.68 | 466.39 |
Repurchase of Common Stock | -363.5 | -299.25 | -121.49 | - | - | - |
Net Common Stock Issued (Repurchased) | -352.64 | -287.84 | -112.07 | 6.47 | 6.68 | 466.39 |
Other Financing Activities | 0.13 | 0.87 | -5.37 | 0.87 | -0.6 | -18.41 |
Financing Cash Flow | -467.51 | -386.98 | 57.57 | -47.04 | -2.67 | 394.86 |
Net Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Net Cash Flow | -22.53 | 22.98 | -108.03 | 149.71 | 28.85 | -103.39 |
Free Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Free Cash Flow | 487.64 | 455.13 | 337.77 | 241.13 | 147.28 | 132.09 |
Free Cash Flow Growth | 44.39% | 34.74% | 40.08% | 63.73% | 11.50% | -21.62% |
FCF Margin | 36.47% | 34.65% | 28.15% | 24.12% | 17.09% | 17.46% |
Free Cash Flow Per Share | 5.64 | 5.20 | 3.80 | 2.77 | 1.74 | 1.59 |
Levered Free Cash Flow | 131.7 | 246.96 | 438.65 | 127.65 | 99.14 | 43.7 |
Unlevered Free Cash Flow | 399.39 | 381.88 | 302.24 | 213.7 | 140.25 | 125.02 |